400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2400080109
正在进行
/
/
/
2024-01-19
/
/
ADHD
A Randomized Controlled Trial of Physical Activity Intervention on Neurocognitive Performance, Mental Health, and Behavioural Outcomes of Children with Attention Deficit Hyperactivity Disorder
A Randomized Controlled Trial of Physical Activity Intervention on Neurocognitive Performance, Mental Health, and Behavioural Outcomes of Children with Attention Deficit Hyperactivity Disorder
1. Examine the immediate, short- and longer-term effects of a school-based physical activity intervention on neurocognitive performance (inhibitory control, attentional control), mental health (anxiety and depression), and behavioural outcomes (e.g., social withdrawal and aggressive behaviour) in children with ADHD. 2. Determine the potential influence of the moderating variables (gender, ADHD subtypes) on the intervention effects.
整群随机分组
其它
Six schools will be cluster-randomized into either intervention schools or control schools using block size randomization in a 1:1 ratio. The random number sequence will be generated by an independent researcher. A computerized randomization tool will be used to create the random number sequence.
The results of the randomization will be kept confidential from the assessors.
Hong Kong University Grants Committee
/
60
/
2022-11-15
2025-11-15
/
(1) Children between the ages of 6 and 11 years diagnosed with ADHD, as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; (2) capability to follow instructions of the researcher; (3) ability to carry out the prescribed physical activity intervention; (4) ability in reading and comprehending questionnaires; (5) no engagement in regular physical activity training within the last 6 months.;
请登录查看(1) Presence of other medical conditions restricting physical activity capacities; (2) Presence of a complex neurologic disorder (e.g., epilepsy, fragile X syndrome); and (3) Visual and auditory deficits.;
请登录查看The Chinese University of Hong Kong
/
英百瑞生物2025-12-05
艾力斯医药科技2025-12-05
神曦生物NeuExcell2025-12-05
科望医药2025-12-05
宠药生态圈2025-12-05
丁香园 Insight 数据库2025-12-05
佰傲谷BioValley2025-12-05
药精通Bio2025-12-05
医药观澜2025-12-05
贝达药业2025-12-05